GlassScriptPhysician profile
Patrick R Spiering
NPI 1568578094
$1,621.29
in general payments reported to CMS, 2019-2025
22 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,288 · 2020: $29.99 · 2021: $96.42 · 2022: $11.71 · 2023: $15.59 · 2024: $78.47 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $293.26 | 2019-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $263.54 | 2019 | |
| Lilly USA, LLC | $122.19 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $113.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.75 | 2019 | |
| Supernus Pharmaceuticals, INC. | $90.24 | 2019 | |
| Allergan, INC. | $67.75 | 2019-2020 | |
| Exact Sciences Corporation | $65.32 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $61.39 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $54.36 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.87 | 2019 | |
| Merck Sharp & Dohme LLC | $52.39 | 2019 | |
| Glaxosmithkline, LLC. | $39.50 | 2019-2023 | Arexvy |
| Sanofi-Aventis U.S. LLC | $36.82 | 2019 | |
| Amgen INC. | $34.77 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $30.81 | 2019 | |
| Dynavax Technologies Corporation | $30.73 | 2024 | Heplisav-B |
| Shire North American Group INC | $25.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.17 | 2019 | |
| Abbvie INC. | $19.85 | 2019 | |
| Shionogi INC | $19.20 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Spiering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.